NewGenIvf (NIVF) Net Income towards Common Stockholders (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Net Income towards Common Stockholders of -$7.7 million for Q4 2025, down 1322.06% YoY from $631498.7 in Q4 2024, and down 146.08% sequentially from $16.7 million in Q3 2025.
NewGenIvf (NIVF) Net Income towards Common Stockholders (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed Net Income towards Common Stockholders across 2 years of filings, most recently posting -$7.7 million for Q4 2025.
- In Q4 2025, Net Income towards Common Stockholders fell 1322.06% year-over-year to -$7.7 million; the TTM figure through Dec 2025 stood at $8.5 million (up 1581.26% YoY), while the FY2025 annual figure was $9.7 million, up 2152.04% from the prior year.
- Net Income towards Common Stockholders fell to -$7.7 million in Q4 2025, from $16.7 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for NIVF reached as high as $16.7 million in Q3 2025 and fell as low as -$7.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 1.86 Bn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 66.30 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 702.00 Mn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 275.04 Mn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 15.90 Mn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 96.31 Mn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 348.68 Mn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 80.67 Mn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -1.11 Bn |
| 10 | NewGenIvf | 25,304.95 | -1.41 Mn | 524,025.00 | -7.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.72 Mn |
| Sep 30, 2025 | 16.75 Mn |
| Dec 31, 2024 | -542,684.00 |
| Sep 30, 2024 | -30,342.00 |